GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alvotech (OISE:ALVO) » Definitions » YoY EBITDA Growth

Alvotech (OISE:ALVO) YoY EBITDA Growth : 66.99% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Alvotech YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Alvotech's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 66.99%.

Alvotech's EBITDA per Share for the three months ended in Mar. 2024 was kr-18.97.

Alvotech YoY EBITDA Growth Historical Data

The historical data trend for Alvotech's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alvotech YoY EBITDA Growth Chart

Alvotech Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
- -79.64 77.68 -1,308.60 5.34

Alvotech Quarterly Data
Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -44.47 133.21 -571.32 21.90 66.99

Alvotech YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Alvotech's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(-298.586--315.443)/ | -315.443 |
=5.34 %

Alvotech's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (Q: Mar. 2024 )
=(EBITDA per Share (Q: Mar. 2024 )-EBITDA per Share (Q: Mar. 2023 )) / | EBITDA per Share (Q: Mar. 2023 )) |
=(-18.967--57.466)/ | -57.466 |
=66.99 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alvotech YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Alvotech's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Alvotech (OISE:ALVO) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alvotech (OISE:ALVO) » Definitions » YoY EBITDA Growth
Comparable Companies
AMPH DVAX PBH IRWD TARO PCRX SUPN TLRY ANIP DCPH ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
ALVO:USA Z45:Germany
Address
9, rue de Bitbourg, Luxembourg, LUX, L-1273
Website
https://www.alvotech.com
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.